Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Marketable Securities : ¥22.6 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Chengdu Olymvax Biopharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Chengdu Olymvax Biopharmaceuticals's Marketable Securities for the quarter that ended in Mar. 2025 was ¥22.6 Mil.

Chengdu Olymvax Biopharmaceuticals's annual Marketable Securities declined from Dec. 2022 (¥90.0 Mil) to Dec. 2023 (¥0.0 Mil) but then increased from Dec. 2023 (¥0.0 Mil) to Dec. 2024 (¥17.5 Mil).

Chengdu Olymvax Biopharmaceuticals Marketable Securities Historical Data

The historical data trend for Chengdu Olymvax Biopharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Olymvax Biopharmaceuticals Marketable Securities Chart

Chengdu Olymvax Biopharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

10.00

200.00

90.00

17.50

Chengdu Olymvax Biopharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Marketable Securities	Get a 7-Day Free Trial															29.00	60.00	77.00	17.50	22.60

Chengdu Olymvax Biopharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Chengdu Olymvax Biopharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Olymvax Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Olymvax Biopharmaceuticals Inc (SHSE:688319) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

99 Tianxin Road, High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.olymvax.com

Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.

Executives

Chen Dao Yuan	Core technical personnel
Li Hong Guang	Core technical personnel
Fan Shao Wen	Directors, senior managers
Ma Heng Jun	senior management
Wu Wei	senior management
Fan Fan	Director
Chen Ai Min	Director
Tan Yong	senior management
Lu Lu	Director
Yu Yun Hui	Director
Zhang Li Ying	Core technical personnel
Chen Ke Ping	Core technical personnel
Wu Qiang	Core technical personnel
Yang Feng	Core technical personnel

Chengdu Olymvax Biopharmaceuticals Headlines

No Headlines